Online Exclusives

Online Exclusives

Are Hospital Leaders Doing Enough to Address Supply Chain Issues?

A poll by consulting firm Sage Growth Partners on behalf of inventory management platform Syft found that among 100 organizations, 93% have taken action...

EZM0414 Granted Fast Track Designation for DLBCL

The U.S. Food and Drug Administration (FDA) has granted fast track designation to oral SETD2 inhibitor EZM0414 as an investigational agent for the treatment...

“Health Equity Tourism” Does More Harm Than Good for Racial Disparities in Medicine

Following the National Institutes of Health (NIH) announcement that it would provide $100 million in health equity research funding after the COVID-19 pandemic and...

Could an AI Algorithm Diagnose DVT More Efficiently?

Researchers from the University of Oxford and the University of Sheffield have teamed up with U.K. startup ThinkSono to develop a machine learning artificial...

Female Physicians Face Higher Rates of Infertility and Pregnancy Complications

As female physicians tend to delay pregnancy until after their residencies, they are more susceptible to fertility issues. Nearly one in four female physicians...
Sickle cell anemia

Voxelotor Granted Priority Review for Children With Sickle Cell Disease

The U.S. Food and Drug Administration (FDA) has accepted Global Blood Therapeutics’ (GBT’s) supplemental New Drug Application (sNDA) seeking accelerated approval for voxelotor for...

Ruxolitinib Approved for Chronic Graft-Versus-Host Disease

The FDA has approved ruxolitinib for the treatment of chronic graft-versus-host disease (cGVHD) in adult and pediatric patients 12 years and older whose disease...

Medicare Drug Price Negotiation Plan Continues to Face Opposition

At least three House Democrats and one Senate Democrat oppose giving Medicare the ability to negotiate lower drug prices, putting the provision in danger...

FDA Places Clinical Hold on Trials of AZD5991 Following Cardiac Complications

On October 9, the U.S. Food and Drug Administration (FDA) placed a clinical hold on a trial assessing AstraZeneca’s AZD5991 in combination with venetoclax...

How Can FDA Regulation Build Transparency into Health Care AI Tools?

In October, the U.S. Food and Drug Administration (FDA) held a workshop on the regulation of artificial intelligence (AI) in health care. While the FDA...
Advertisement

Current Issue

December 2021 Volume 7 Issue 15

This issue explores doctor deserts, celebrates the 50th anniversary of the National Cancer Act, and more.

Block title